nach oben

Journal of Clinical Immunology

Erschienen in:

01.09.2006

Autoantibodies to Mitotic Apparatus: Association with Other Autoantibodies and Their Clinical Significance

verfasst von: BRANKA BONACI-NIKOLIC, SLADJANA ANDREJEVIC, MIRJANA BUKILICA, IVANA UROSEVIC, MILOS NIKOLIC

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

The most important mitotic apparatus (MA) antigens are centrosome (CE), nuclear mitotic apparatus (NuMA-1, NuMA-2), midbody, and centromere F (CENP-F). We studied associations of anti-MA antibodies with other autoantibodies and their clinical significance. A total of 6270 patients were studied for the presence of anti-MA antibodies on HEp-2 cells. Sera positive for anti-MA were tested for anti-extractable nuclear antigens (ENA) antibodies. Anti-MA antibodies were detected in 56 (45 females and 11 males) of 6270 sera (0.9%). Of these 56, NuMA-1 was found in 23, NuMA-2 in 7, CE in 20, CENP-F in 5, and CENP-F/centrosome in 1 case. Anti-NuMA-1 were associated with anti-ENA antibodies (p < 0.001). Diagnoses were established in 43/56 patients: 22 connective tissue diseases, 7 infections, 6 autoimmune hepatitis, 3 vasculitis, 3 primary antiphospholipid syndrome, 1 malignancy, and 1 fever of unknown origin. The differential diagnosis of anti-NuMA-1-positive patients must include Sjögren’s syndrome, while patients with anti-CE antibodies must be observed for HCV infection.

Fritzler MJ, Rattner JB: Autoantibodies to the mitotic apparatus: Biological breakthroughs, clinical application, etiological complexity. In Autoantigens and Autoantibodies: Diagnostic Tools and Clues to Understanding Autoimmunity, K Conrad, RL Humbel, et al. (eds). Berlin, Pabst Science, 2000, pp 58–86

Ou Y, Rattner JB: A subset of centrosomal proteins are arranged in a tubular conformation that is reproduced during centrosome duplication. Cell Motil Cytoskeleton 47:13–24, 2000PubMedCrossRef

Kisurina-Evgenieva O, Mack G, Du Q, Macara I, Khodjakov A, Compton DA: Multiple mechanisms regulate NuMA dynamics at spindle poles. J Cell Sci 117:6391–6400, 2004PubMedCrossRef

Bradwell AR, Hughes RG, Harden EL: Atlas of HE-p 2 Patterns. Birmingham, Drapkins, 2003

Casiano CA, Martin SJ, Green DR, Tan EM: Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med 184:765–770, 1996PubMedCrossRef

Ramirez-Sandoval R, Sanchez-Rodriguez SH, Herrera-van Oostdam D, Avalos-Diaz E, Herrera-Esparza R: Antinuclear antibodies recognize cellular autoantigens driven by apoptosis. Joint Bone Spine 70:187–194, 2003PubMedCrossRef

Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface blebs on apoptotic keratinocytes. J Exp Med 179:1317–1330, 1994PubMedCrossRef

Andrade LE, Chan EK, Peebles CL, Tan EM: Two major autoantigen–antibody systems of the mitotic spindle apparatus. Arthritis Rheum 39:1643–1653, 1996PubMedCrossRef

Huidbuchel E, Blaschek M, Seigneurin JM, Lamour A, Berthelot JM, Youinou P: Anti-organelle and anti-cytoskeletal autoantibodies in the serum of Epstein-Barr virus-infected patients. Ann Med Intern (Paris) 142:343–346, 1991

10.

Abu-Shakra M, Buskila D, Ehrenfeld M, Conrad K, Shoenfeld Y: Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 60:433–441, 2001PubMedCrossRef

11.

Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725, 1997PubMedCrossRef

12.

Sharp GC: Diagnostic criteria for classification of MCTD. In Mixed Connective Tissue Diseases and Antinuclear Antibodies, R Kasukawa, GC Sharp (eds). Amsterdam, Elsevier, 1987, pp 23–32

13.

Anonymous: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Arthritis Rheum 23:581–590, 1980CrossRef

14.

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH: European Study Group on Classification Criteria for Sjogren’s Syndrome. Classification criteria for Sjogren’s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558, 2002PubMedCrossRef

15.

Bohan A, Peter JB: Polymyositis and dermatomyositis. N Engl J Med 292:344–347, 1975PubMedCrossRef

16.

Mosca M, Neri R, Stringini F, Carmignani A, Totti D, Tavoni A, Bombardieri S: Pregnancy outcome in patients with undifferentiated connective tissue disease: A preliminary study on 25 pregnancies. Lupus 11:304–307, 2002PubMedCrossRef

17.

Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA: International consensus statement on preliminary classification for definite antiphospholipid syndrome. Arthritis Rheum 42:1309–1311, 1999PubMedCrossRef

18.

Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al.: International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929–938, 1999PubMedCrossRef

19.

Jennette JC, Falk RJ: Small-vessels vasculitis. N Engl J Med 20:1512–1523, 1997CrossRef

20.

Radice A, Vecchi M, Bianchi MB, Sinico RA: Contribution of immunoflorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Clin Exp Rheum 18:707–1712, 2000

21.

Auer-Grumbach P, Achleitner B: Epidemiology and clinical associations of NuMA (Nuclear Mitotic Apparatus Protein) autoantibodies. J Rheumatol 21:1779–1781, 1994PubMed

22.

Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ: Antinuclear, anticytoplasmic and anti Sjogren syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 36:120–128, 1985PubMedCrossRef

23.

Taimen P, Viljamaa M, Kallajoki M: Preferential expression of NuMA in the nuclei of proliferating cells. Exp Cell Res 256:140–149, 2000PubMedCrossRef

24.

Kammerer S, Roth RB, Hoyal CR, Reneland R, Marnellos G, Kiechle M, et al.: Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility. Proc Natl Acad Sci USA 102:2004–2009, 2005PubMedCrossRef

25.

Yang CH, Lambie EJ, Snyder M: NuMA: An unusually long coiled-coil related protein in the mammalian nucleus. J Cell Biol 116:1303–1317, 1992PubMedCrossRef

26.

Whitehead CM, Winkfein RJ, Fritzler MJ, Rattner JB: The spindle kinesin-like protein HsEg5 is an autoantigen in systemic lupus erythematosus. Arthritis Rheum 39:1635–1642, 1996PubMedCrossRef

27.

Rattner JB, Martin L, Waisman DM, Johnstone SA, Fritzler MJ: Autoantibodies to the centrosome (centrosome) react with determinants present in the glycolytic enzyme enolase. J Immunol 146:2341–2344, 1991PubMed

28.

Liao H, Winkfein RJ, Mack G, Rattner JB, Yen TJ: CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis. J Cell Biol 130:507–518, 1995PubMedCrossRef

29.

Casiano CA, Landberg G, Ochs RL, Tan EM: Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during S phase and is localized in the kinetochores and spindle midzone during mitosis. J Cell Sci 106:1045–1056, 1993PubMed

30.

Hansen BU, Eriksson S, Lindgren S: High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere, and mitotic spindle antibodies. Scand J Gastroenterol 26:707–713, 1991PubMedCrossRef

31.

Grypiotis P, Ruffatti A, Tonello M, Winzler C, Radu C, Zampieri S, et al.: Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases. Reumatismo 54:232–237, 2002PubMed

32.

McCarty GA, Valencia DW, Fritzler MJ: Antibody to the mitotic spindle apparatus: immunologic characteristics and cytologic studies. J Rheumatol 11:213–218, 1984PubMed

33.

Hassfeld W, Chan EK, Mathison DA, Portman D, Dreyfuss G, Steiner G, Tan EM: Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: Immunological relationship with hnRNP P. Nucleic Acids Res 26:439–445, 1998PubMedCrossRef

34.

Zeng C, He D, Berget SM, Brinkley BR: Nuclear-mitotic apparatus protein: A structural protein interface between the mucleoskeleton and RNA splicing. Proc Natl Acad Sci USA 91:1505–1509, 1994PubMedCrossRef

35.

Hsu HL, Yeh NH: Dynamic changes of NuMA during the cell cycle and possible appearance of a truncated form of NuMA during apoptosis. J Cell Sci 109:277–288, 1996PubMed

36.

Price CM, McCarty GA, Pettijohn DE: NuMA protein is a human autoantigen. Arthritis Rheum 27:774–779, 1984PubMedCrossRef

37.

Sato S, Fujimoto M, Ihn H, Takehara K: Antibodies to centromere and centrosome in scleroderma spectrum disorders. Dermatology 89:23–26, 1994CrossRef

38.

Fritzler MJ, Manns MP: Anti-mitochondrial antibodies. Clin Appl Immunol Rev 3:87–113, 2002CrossRef

39.

Ramos-Casals M, Jara LJ, Medina F, Rosas J, Calvo-Alen, Mana J, et al.: Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the Hispamec Registry): Patterns of clinical and immunological expression in 180 cases. J Intern Med 57:549–557, 2005CrossRef

40.

Gentric A, Blaschek M, Julien C, Jouquan J, Pennec Y, Berthelot JM, et al.: Nonorgan-specific autoantibodies in individuals infected with type 1 human immunodeficiency virus. Clin Immunol Immunopathol 59:487–494, 1991PubMedCrossRef

41.

Bencimon C, Salles G, Moreira A, Guyomard S, Coiffier B, Bienvenu J, Fabien N: Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin’s lymphoma. Ann NY Acad Sci 1050:319–326, 2005PubMedCrossRef

42.

Zhang JY, Zhu W, Imai H, Kiyosawa K, Chan EK, Tan EM: De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma. Clin Exp Immunol 125:3–9, 2001PubMedCrossRef

43.

Rattner JB, Rees J, Whitehead CM, Casiano CA, Tan EM, Humbel RL, et al.: High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clin Invest Med 20:308–319, 1997PubMed

Titel: Autoantibodies to Mitotic Apparatus: Association with Other Autoantibodies and Their Clinical Significance
verfasst von: BRANKA BONACI-NIKOLIC
SLADJANA ANDREJEVIC
MIRJANA BUKILICA
IVANA UROSEVIC
MILOS NIKOLIC
Publikationsdatum: 01.09.2006
Verlag: Springer US
Erschienen in: Journal of Clinical Immunology / Ausgabe 5/2006
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-006-9038-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2006

Ex-Vivo Analysis of CD8+ T Cells Infiltrating Colorectal Tumors Identifies a Major Effector-Memory Subset with Low Perforin Content

Effect of Palifermin in a Murine Model of Graft-Versus-Host Disease (GVHD) Associated with Th2 Cytokine Production, Autoantibody Production, and Glomerulonephritis

Inhibition of Alpha Nascent Polypeptide Associated Complex Protein May Induce Proliferation, Differentiation and Enhance the Cytotoxic Activity of Human CD8+ T Cells

Vasoactive Intestinal Polypeptide Suppressed Experimental Autoimmune Encephalomyelitis by Inhibiting T Helper 1 Responses

Gene Polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in Exposed but Uninfected Partners of HIV-1 Infected Individuals in North India